OrganoClick AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was SEK 38.53 million compared to SEK 39.82 million a year ago. Net loss was SEK 8.81 million compared to SEK 6.39 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to SEK 0.07 a year ago.
For the six months, sales was SEK 71.16 million compared to SEK 69.48 million a year ago. Net loss was SEK 14.71 million compared to SEK 12.72 million a year ago. Basic loss per share from continuing operations was SEK 0.15 compared to SEK 0.14 a year ago.